Results 201 to 210 of about 9,861 (247)
Some of the next articles are maybe not open access.
Journal of Child Neurology, 2023
Background: Infantile epileptic spasms syndrome is an epileptic encephalopathy, characterized by spasms, hypsarrhythmia, and developmental regression. Appropriately selected patients with infantile epileptic spasms syndrome may be candidates for epilepsy
Jennifer V. Gettings +9 more
semanticscholar +1 more source
Background: Infantile epileptic spasms syndrome is an epileptic encephalopathy, characterized by spasms, hypsarrhythmia, and developmental regression. Appropriately selected patients with infantile epileptic spasms syndrome may be candidates for epilepsy
Jennifer V. Gettings +9 more
semanticscholar +1 more source
IEEE transactions on neural systems and rehabilitation engineering
Objective: In infantile epileptic spasms syndrome (IESS), relapse following initial effective adrenocorticotropic hormone (ACTH) treatment presents a significant challenge, involving complex neuronal oscillation interactions.
Chuting Zhang +4 more
semanticscholar +1 more source
Objective: In infantile epileptic spasms syndrome (IESS), relapse following initial effective adrenocorticotropic hormone (ACTH) treatment presents a significant challenge, involving complex neuronal oscillation interactions.
Chuting Zhang +4 more
semanticscholar +1 more source
Epilepsy & Behavior, 2023
Infantile epileptic spasms syndrome (IESS) is characterized by epileptic spasms, regardless of hypsarrhythmia on electroencephalogram or neurodevelopmental delay. In Japan, pyridoxal 5'-phosphate (PLP) is often used as the first-line treatment for IESS because it is effective in a certain number of patients.
Yuto Arai +6 more
openaire +2 more sources
Infantile epileptic spasms syndrome (IESS) is characterized by epileptic spasms, regardless of hypsarrhythmia on electroencephalogram or neurodevelopmental delay. In Japan, pyridoxal 5'-phosphate (PLP) is often used as the first-line treatment for IESS because it is effective in a certain number of patients.
Yuto Arai +6 more
openaire +2 more sources
Epilepsia
For patients with infantile epileptic spasms syndrome (IESS) who have achieved remission of epileptic spasms (ES), indicators of how well the electroencephalographic (EEG) state should be maintained during follow‐up are not available.
Masahiro Umeda +8 more
semanticscholar +1 more source
For patients with infantile epileptic spasms syndrome (IESS) who have achieved remission of epileptic spasms (ES), indicators of how well the electroencephalographic (EEG) state should be maintained during follow‐up are not available.
Masahiro Umeda +8 more
semanticscholar +1 more source
Effectiveness of vigabatrin for infantile epileptic spasm syndrome categorized by etiologies
Seizure: European Journal of EpilepsyWe aimed to assess the effectiveness of vigabatrin (VGB) in patients diagnosed with infantile epileptic spasm syndrome (IESS) and categorize these patients based on their etiologies.This retrospective study included patients diagnosed with IESS who exhibited epileptic spasms before the age of 2 years between January 1, 2015, and October 31, 2023 at ...
Hirokazu Takeuchi +8 more
openaire +2 more sources
Novel copy number variations and phenotypes of infantile epileptic spasms syndrome
Clinical GeneticsAbstract We summarize the copy number variations (CNVs) and phenotype spectrum of infantile epileptic spasms syndrome (IESS) in a Chinese cohort. The CNVs were identified by genomic copy number variation sequencing. The CNVs and clinical data were analyzed. 74 IESS children with CNVs were enrolled.
Miaomiao Cheng +10 more
openaire +2 more sources
Seizure: European Journal of Epilepsy
Infantile epileptic spasms syndrome (IESS) often has a severe neurodevelopmental prognosis. However, few studies have examined the aspect of elementary school enrollment. This study evaluated elementary school enrollment after adrenocorticotropic hormone (ACTH) therapy in patients with IESS.We retrospectively evaluated the elementary school enrollment ...
Ryuki Matsuura +8 more
openaire +2 more sources
Infantile epileptic spasms syndrome (IESS) often has a severe neurodevelopmental prognosis. However, few studies have examined the aspect of elementary school enrollment. This study evaluated elementary school enrollment after adrenocorticotropic hormone (ACTH) therapy in patients with IESS.We retrospectively evaluated the elementary school enrollment ...
Ryuki Matsuura +8 more
openaire +2 more sources
Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology
Epilepsy ResearchEpileptic spasms are the primary symptom of infantile epileptic spasms syndrome (IESS); however, their direct impact on blood-brain barrier (BBB) function is unknown. Matrix metallopeptidase-9 (MMP-9), degrades type IV collagen, a key component of the blood-brain barrier, while tissue inhibitor of metalloproteinase-1 (TIMP-1) suppresses its activity ...
Ryuki, Matsuura +7 more
openaire +2 more sources
Contribution of Cross-Phase-Amplitude Coupling to Relapse in Infantile Epileptic Spasms Syndrome
2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)Relapse poses a significant challenge after the initial effectiveness of adrenocorticotropic hormone treatment in infantile epileptic spasms syndrome (IESS), involving complex neuronal oscillations interactions. Phase-amplitude coupling (PAC) extensively characterizes mutual interactions among rhythmic activities in pathological conditions.
Chuting, Zhang +4 more
openaire +2 more sources

